跳至主要内容
临床试验/JPRN-UMIN000027695
JPRN-UMIN000027695已完成未知

A non-interventional study to investigate the proportion, characteristics and treatment reality of adult patients with severe and uncontrolled severe asthma using a claims database - KEIFU study

Astrazeneca K.K0 个研究点目标入组 20,000 人开始时间: 2017年6月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20,000

研究概览

简要总结

The primary analysis set consisted of 10,579 'athma patients under treatment'. 'Athma patients under treatment' included 823 'severe asthma patients'(7.8%). The number (%) of 'uncontrolled severe asthma patients' was 267 patients (2.5%), and that of 'non-severe patients' was 9,756 (92.2%). Compared to 'non-severe patients', 'uncontrolled severe asthma patients' had a higher frequency in asthma exacerbation and more expensive direct medical expenditure. Also, compared to 'non-severe patients', 'uncontrolled severe asthma patients' had a higher amount of use of systemic steroids.

研究设计

研究类型
Observational

入排标准

年龄范围
17years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Patients who didin't have the "claims with for an asthma and record of ICS or ICS/LABA prescription for that visit" within 6 months prior to Index date -Patients who didin't have the "claims with for an asthma and record of ICS or ICS/LABA prescription for that visit" during the period of more than 6 months and within 12 months prior to Index date

研究者

相似试验